6MI2
Structure of the human 4-1BB / Utomilumab Fab complex
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 5.0.1 |
| Synchrotron site | ALS |
| Beamline | 5.0.1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2017-06-16 |
| Detector | DECTRIS PILATUS3 6M |
| Wavelength(s) | 0.97741 |
| Spacegroup name | I 1 2 1 |
| Unit cell lengths | 136.903, 73.338, 175.121 |
| Unit cell angles | 90.00, 98.99, 90.00 |
Refinement procedure
| Resolution | 49.303 - 2.720 |
| R-factor | 0.24 |
| Rwork | 0.238 |
| R-free | 0.27780 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Data reduction software | XDS |
| Data scaling software | Aimless (0.5.32) |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 49.303 | 49.300 | 2.820 |
| High resolution limit [Å] | 2.720 | 10.530 | 2.720 |
| Rmerge | 0.350 | 0.037 | 4.509 |
| Rmeas | 0.379 | 0.041 | 4.869 |
| Rpim | 0.143 | 0.016 | 1.824 |
| Number of reflections | 46410 | 846 | 4497 |
| <I/σ(I)> | 6.8 | ||
| Completeness [%] | 100.0 | 98.9 | 100 |
| Redundancy | 6.9 | 6.3 | 7 |
| CC(1/2) | 0.985 | 0.999 | 0.235 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 7 | 295 | 1.5M lithium sulfate, 0.1M HEPES pH 7.0 |






